Key stakeholders
These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates
Latest news about Abbott Laboratories
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Abbott Laboratories reported strong first-quarter 2025 results, with a 6.9% organic sales increase to $10.4 billion and adjusted EPS of $1.09, exceeding consensus. Medical Devices sales rose 13% organically, led by a 20% increase in Diabetes Care. The company reaffirmed full-year guidance and announced $0.5 billion in new manufacturing and R&D investments[3][4][5].
Abbott Laboratories anticipates a financial impact of "a few hundred million dollars" from tariffs in 2025, but has strategies to mitigate these effects. The company is also investing $0.5 billion in new manufacturing and R&D facilities in Illinois and Texas, set to open by year's end[2][5].
Abbott Laboratories' stock price is on track to hit a new high in 2025, driven by a 5% increase following the Q1 results, strong segment growth, and a reliable dividend. The company is expanding its manufacturing and R&D facilities in Illinois and Texas with a $0.5 billion investment, set to go live by the end of 2025[4].
Open job positions at Abbott Laboratories
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
Senior Nutrition Sales Executive - Mumbai
Territory Business Manager-Osvita-Nashik
Area Business Manager - Vizag

